[Clinical analysis of evisceration with hydroxyapatite implant].
To evaluate the clinical effect and safety of evisceration with hydroxyapatite (HA) orbital implant. A retrospective analysis of all eviscerations with HA implant performed between January 1998 and May 2000 in Zhongshan Ophthalmic Center was completed. Patient records were reviewed for demographic data, surgical indication, sphere size, clinical outcome, and complications. The average follow-up interval was 11.6 months (2-24 months). Primary evisceration with HA implantation was performed in total 78 cases. All patients underwent successful surgery without major complications. There was no case with those complications, including implant extrusion, exposure and implant dislocation, in the series examination. No patient has symphathetic ophthalmia during follow-up interval. In strict selected cases with surgical indication of evisceration, primary evisceration with HA implantation is a safe and effective method for treating patients with a blind, painful or atrophic eye.